Prognostic and predictive significance of the pan-immune-inflammation value in endometrial cancer patients undergoing adjuvant therapy
The PIV score is a significant prognostic marker for survival in endometrial cancer patients receiving adjuvant chemotherapy. Patients with a high PIV score may benefit from the addition of radiotherapy to their treatment regimen. Further studies are needed to validate the PIV score as a predictive marker for adjuvant radiotherapy in this population.
Authors
- Arif Akyıldız (ORCID: https://orcid.org/0000-0002-4452-2076)
- Zafer Arık (ORCID: https://orcid.org/0000-0002-0598-389X)
- Elvin Chalabıyev (ORCID: https://orcid.org/0000-0001-6470-6043)
- Fatih Kuş (ORCID: https://orcid.org/0000-0003-1650-154X)
- Hasan Çağrı Yıldırım (ORCID: https://orcid.org/0000-0003-3060-377X)
- Rashad İsmayılov (ORCID: https://orcid.org/0000-0002-7093-2722)
- Gözde Kavgacı (ORCID: https://orcid.org/0000-0001-6960-2024)
- Beril Kırmızıgül (ORCID: https://orcid.org/0009-0001-0698-1079)
- Deniz Can Güven (ORCID: https://orcid.org/0000-0002-6924-9467)
- Barış Köksal (ORCID: https://orcid.org/0000-0002-0418-5749)
Institutions
- Cancer Institute (WIA) (IN)
- Hacettepe University Hospital (TR)
- Hacettepe University (TR)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2025-06-07
- DOI
- https://doi.org/10.5603/rpor.105859
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06